Bvf Inc Axsome Therapeutics, Inc. Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 1,388,064 shares of AXSM stock, worth $191 Million. This represents 4.4% of its overall portfolio holdings.
Number of Shares
1,388,064
Previous 1,046,000
32.7%
Holding current value
$191 Million
Previous $94 Million
24.96%
% of portfolio
4.4%
Previous 2.99%
Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$558 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$455 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$202 Million24.98% of portfolio
-
Ra Capital Management, L.P. Boston, MA1MShares$138 Million1.37% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.91B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...